2019, Number 1
Cardiovascular rehabilitation evidence-based of cardiac involvement associated with neuromuscular diseases
Language: Spanish
References: 7
Page: 1-5
PDF size: 112.33 Kb.
Text Extraction
No abstract.REFERENCES
Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, et al. Management of cardiac involvement in neuromuscular diseases. A Scientific Statement from the American Heart Association. Circulation. 2017 [acceso: 03/01/2018]; 136:e200-31. DOI: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000526
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Care Considerations Working Group. Diagnosis and management of Duchenne Muscular Dystrophy, part 1: Diagnosis, and Pharmacological and Psychosocial Management. Lancet Neurol. 2010 [acceso: 03/01/2018]; 9:77-93. Disponible en: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70271-6/fulltext
Bushby K, Muntoni F, Urtizberea A, Hughes R, Griggs R. Report on the 124th ENMC International Workshop: Treatment of Duchenne Muscular Dystrophy; Defining the Gold Standards of Management in the Use of Corticosteroids. 2-4 April 2004. [acceso: 03/01/2018]; 14:526-34. Disponible en: https://www.nmd-journal.com/article/S0960- 8966(04)00132-4/fulltext
Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G, et al. Guideline Development Subcommittee of the American Academy of Neurology; Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2014 [acceso: 03/01/2018]; 83(16):1453-63. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206155/